Top

Published in:

19-03-2024 | Mesothelioma | ASO Author Reflections

ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma

Authors: Varun V. Bansal, MBBS, Owen Mitchell, BS, Michael W. Drazer, MD, PhD, Hedy L. Kindler, MD, Kiran K. Turaga, MD, MPH, FACS

Published in: Annals of Surgical Oncology | Issue 6/2024

Excerpt

Venous thromboembolism (VTE) represents a significant concern in patients with abdominal malignancies. Despite historical reports highlighting clotting abnormalities in peritoneal mesothelioma (PeM) patients and the acknowledged risk associated with cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and systemic chemotherapy, large-scale studies on VTE in PeM are lacking.^1,2 …

Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983;1(6):386–91. https://doi.org/10.1200/JCO.1983.1.6.386.CrossRefPubMed

Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM. Incidence, risk factors, and prevention strategies for venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(7):2276–84. https://doi.org/10.1245/s10434-019-07414-8.CrossRefPubMed

Bansal VV, Mitchell O, Bregio C, et al. Venous thromboembolism in peritoneal mesothelioma: uncovering the hidden risk. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15030-4.CrossRefPubMed

Dhiman A, Fenton E, Whitridge J, et al. Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for patients undergoing cytoreductive surgery with or without HIPEC. Ann Surg Oncol. 2021;28(12):6955–64. https://doi.org/10.1245/s10434-021-09973-1.CrossRefPubMed

Hübner M, Kusamura S, Villeneuve L, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without Hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS^®) Society recommendations—Part I: preoperative and intraoperative management. Eur J Surg Oncol. 2020;46(12):2292–310. https://doi.org/10.1016/j.ejso.2020.07.041.CrossRefPubMed

Title: ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma
Authors: Varun V. Bansal, MBBS
Owen Mitchell, BS
Michael W. Drazer, MD, PhD
Hedy L. Kindler, MD
Kiran K. Turaga, MD, MPH, FACS
Publication date: 19-03-2024
Publisher: Springer International Publishing
Keyword: Mesothelioma
Published in: Annals of Surgical Oncology / Issue 6/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-024-15155-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2024

Efficacy Assessment of Post-nephrectomy Adjuvant Therapies in Patients with Renal Cell Carcinoma

Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis

ASO Author Reflections: Advancing the Frontiers of Robotic Pancreaticoduodenectomy: Where are We Headed?

Combination of a Glissonean Approach and Indocyanine Green Fluorescence Imaging to Perform a Laparoscopic Right Anterior Sectionectomy

Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy

ASO Author Reflections: A Call for Updated Recommendations for Germline Mutation Testing in Patients with Primary Hyperparathyroidism